Ma Dongjiu cancelled the agreement to acquire 51% stake in Xilong Medical Technology Co., Ltd from Xilong Scientific Co., Ltd..
January 09, 2018
Share
Ma Dongjiu agreed to acquire 51% stake in Xilong (Shanghai) Medical Technology Co., Ltd from Xilong Scientific Co., Ltd. (SZSE:002584) for CNY 25.5 million on January 10, 2017. Under the terms, Xilong Scientific Co., Ltd. will sell its entire 51% stake. As at September 30, 2016, Xilong (Shanghai) Medical Technology Co., Ltd. had total assets of CNY 74.65 million and net assets of CNY 54.19 million and for the period ended September 30, 2016, revenue of CNY 56.68 million and net profit of CNY 2.04 million. The transaction was approved by the Board of Directors of Xilong Scientific Co., Ltd. in its 3rd directorate's 26th meeting.
Ma Dongjiu cancelled the agreement to acquire 51% stake in Xilong (Shanghai) Medical Technology Co., Ltd from Xilong Scientific Co., Ltd. (SZSE:002584) on January 10, 2018.
Xilong Scientific Co Ltd, formerly Xilong Chemical Co Ltd, is principally engaged in the research, development, production and sale of chemical reagents. The Company primarily provides general chemical reagents, including ammonia water, sodium hydroxide, sulfuric acid, nitric acid, carbinol and ethanol; chemical reagents for printed circuit boards (PCBs), as well as super clean high purity chemical reagents. Its chemical reagents are mainly used in electronic information, daily chemicals, medicine, food, as well as sensitization industries. The Company is also involved in chemical raw material, bulk pharmaceutical, food additive, and in-vitro diagnostic substance businesses.
XILONG SCIENTIFIC CO., LTD. 
